¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary isotope effect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary sensation
    ÀÏÂ÷°¨°¢
  • primary sensory area
    ÀÏÂ÷°¨°¢±¸¿ª
  • primary sequestrum
    ÀÏÂ÷ºÎ°ñ, ¿ÏÀüºÐ¸®Á×Àº»À
  • primary sex character
    ÀÏÂ÷¼ºÂ¡
  • primary sex ratio
    ÀÏÂ÷¼ººñ
  • primary sterility
    ¿ø¹ßºÒÀÓ
  • primary suture
    ÀÏÂ÷ºÀÇÕ
  • primary tooth
    ÀÏÂ÷Ä¡¾Æ
  • primary transcript
    ÀÏÂ÷Àü»ç¹°
  • primary tuberculosis
    ¿ø¹ß°áÇÙ
  • spontaneous primary peritonitis
    ¿ø¹ßº¹¸·¿°, ¿ø¹ß¹è¸·¿°
  • antagonistic effect
    ´ëÇ×È¿°ú
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú
  • antioxidant effect
    Ç×»êÈ­È¿°ú
  • antitussive effect
    Ç×±âħȿ°ú, ÁøÇØÈ¿°ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary sequestrum
    ¿ÏÀüºÐ¸®Á×Àº»À, ÃʱâºÎ°ñ, Á¦ÀϱâºÎ°ñ
  • primary sporocyst
    ÀÏÂ÷Æ÷ÀÚ³¶
  • primary stage
    Ãʱâ
  • primary sterility
    ¿ø¹ßºÒÀÓ(Áõ)
  • primary suture
    ÀÏÂ÷ºÀÇÕ
  • primary symptom
    ÀÏÂ÷Áõ»ó
  • primary tooth
    (¢¡deciduous tooth) Á¥´Ï, Å»¶ôÄ¡¾Æ
  • primary immune response
    ÀÏÂ÷¸é¿ª¹ÝÀÀ
  • primary lateral sclerosis
    ¿ø¹ß°¡ÂʰæÈ­Áõ
  • primary sampling unit
    ÀÏÂ÷ÃßÃâ´ÜÀ§
  • primary sex ratio
    ÀÏÂ÷¼ººñ
  • primary signalling system
    ÀÏÂ÷½Åȣü°è
  • acute normal tissue effect
    Á¤»óÁ¶Á÷±Þ¼º¿µÇâ
  • additive effect
    ºÎ°¡È¿°ú, »ó°¡È¿°ú
  • adverse effect
    ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • plateau effect
    °íÆòºÎÈ¿°ú(¡­üùÍý).
  • polarity effect
    ±Ø¼ºÈ¿°ú
  • polarizing effect
    ºÐ±ØÈ¿°ú(¡­üùÍý).
  • pooling effect
    Àú·ùÈ¿°ú(îÍë§üùÍý).
  • pressor effect
    ½Â¾ÐÈ¿°ú(ã°äâüùÍý).
  • priming effect
    ÃÊȸÇ׿øÀÚ±ØÈ¿°ú
  • prolonged effect
    Áö¼ÓÈ¿°ú(ò¥áÙüùÍý), Áö¿¬È¿°ú(òÀæÅüùÍý).
  • protein sparing effect
    ´Ü¹éÁúÀý¾àÈ¿°ú(Ó±ÛÜòõï½å³üùÍý).
  • quadratic effect
    ÀÌÂ÷È¿°ú(¡­üùÍý).
  • radiation effect
    ¹æ»ç¼±È¿°ú
  • radio-frequency thermal effect
    °íÁÖÆÄ ¿­ È¿°ú
  • radioactive effect
    ¹æ»ç´ÉÈ¿°ú
  • Ghon s primary complex
    °ï¿ø¹ßÁõÈıº.
  • amyloidosis primary
    ¿ø¹ß¼º(ê«Û¡àõ) ¾Æ¹Ð·ÎÀ̵åÁõ.
  • immune response, primary
    ÀÏÂ÷¸é¿ª¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • direct piezoelectric effect
    Á÷Á¢ ¾ÐÀü È¿°ú
  • doppler effect
    µµÇ÷¯ È¿°ú (üùÍý)
  • dose rate effect
    ¼±·®À²È¿°ú
  • dose-effect relationship
    ¼±·®¿µÇâ°ü°è
  • double effect
    ÀÌÁßÈ¿°ú
  • drug effect
    ¾à¹°È¿°ú
  • drying effect
    °ÇÁ¶È¿°ú(ËëðÏüùÍý).
  • dual effect
    ÀÌ»ó¼º(ÀÌÁß)È¿°ú.
  • dual effect
    ÀÌ»ó¼º(ì¶ßÒàõ)(ÀÌÁß)È¿°ú.
  • early effect
    Á¶±âÈ¿°ú
  • edge effect
    ¿¬È¿°ú(æÞüùÍý).
  • edge effect
    ¸ð¼­¸®È¿°ú
  • effect
    È¿°ú, ÀÛ¿ë.
  • effect concentration(=activity)
    À¯È¿³óµµ(êóüùÒØÓø)
  • effect, Pasteur
    ÆÄ½ºÆ©¸£È¿°ú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • dual-effect mutant
    ÀÌÁßÈ¿°ú º¯ÀÌü(ì£ñìüùÍýܨì¶ô÷)
  • electrochromic effect
    Àü±âº¯»ö È¿°ú(ï³Ñ¨Ü¨ßäüùÍý)
  • electrophoretic effect
    Àü±â¿µµ¿ È¿°ú(ï³Ñ¨ç¶ÔÑüùÍý)
  • electroviscous effect
    Àü±âÁ¡¼º È¿°ú(ï³Ñ¨ïÄàõüùÍý)
  • enhancement effect
    Áõ°­ È¿°ú (ñòË­üùÍý)
  • extrinsic Cotton effect
    ¿ÜÀμº(èâì×àõ) ÄÚÆ° È¿°ú(üùÍý)
  • Faraday effect
    ÆÐ·¯µ¥ÀÌ È¿°ú(üùÍý)
  • field effect
    ÀåÈ¿°ú(íÞüùÍý)
  • founder effect
    ½ÃÁ¶ È¿°ú(ã·ðÓüùÍý)
  • glucose effect
    ±Û·çÄÚ½º È¿°ú(üùÍý)
  • Haldane effect
    Ȧµ¥ÀÎ È¿°ú(üùÍý)
  • heterotropic effect
    ÀÌÁú È¿°ú(ì¶òõüùÍý)
  • homoptropic effect
    µ¿Áú È¿°ú(ÔÒòõüùÍý)
  • hydrophobic effect
    ¼Ò¼ö È¿°ú(áÂâ©áÂâ©)
  • hyperchromic effect
    Èí±¤Áõ°¡ È¿°ú (ýåÎÃñòÊ¥üùÍý)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
AEF allogenic effect factor; amyloid enhancing factor; aorto-enteric fistula
CE California encephalitis; cardiac enlargement; cardioesophageal; carotid endarterectomy; catamenial e...
CPE cardiac pulmonary edema; chronic pulmonary emphysema; clinical progress exercise; compensation, pens...
CRE cumulative radiation effect; cyclic adenosine monophosphate-response element
DEFNT dose-effect factor for normal tissue
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
NOAEL No Observed Adverse Effect Level
NOEL No Observed Effect Level
NOEC No observed effect concentration
NOE Nuclear Overhauser Effect
NOESY Nuclear Overhauser Effect spectroscopy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • primary non-inflammatory, myogenous pain disorder
    ¿ø¹ß¼ºÀÇ ºñ¿°Áõ¼º ±ÙÀ° µ¿Åë Àå¾Ö
  • primary ossification center
    ÀÏÂ÷ °ñÈ­ Áß½É
  • primary osteogenic irruption
    ÀÏÂ÷ »À ¹ß»ý ÁøÀÔ
  • primary pain
    ¿ø¹ß¼º µ¿Åë, ¿ø¹ß¼º ÅëÁõ
    Ä§ÇØ¼ö¿ë¼º ÀÔ·ÂÀ» À¯¹ßÇÏ´Â ÁøÂ¥ ±Ù¿ø¿¡ À§Ä¡ÇÏ´Â ÅëÁõ.
  • primary process
    ÀÏÂ÷ °úÁ¤
  • primary radiation
    ÀÏÂ÷ ¹æ»ç¼±
  • primary receptive area
    Á¦1¼ö¿ë ¿µ¿ª
    ½Ã°¢, û°¢, Ã˰¢ µî°ú °°Àº ±âº» °¨°¢ÀÇ ½Ã»ó Åõ»ç¸¦ ¹Þ¾ÆµéÀÌ´Â ´ë³ú ÇÇÁú ¿µ¿ª.
  • primary sensation
    ÀÏÂ÷ °¨°¢
  • primary sequestrum
    Ãʱ⠺ΰñ, ºÎ°ñ
  • primary shock
    ÀÏÂ÷¼º ¼ï
  • primary signalling system
    ÀÏÂ÷Àû¡¡½Åȣü°è Á¤½Å
  • primary spermatocyte
    ÀÏÂ÷ Á¤¸ð¼¼Æ÷
    Á¤ÀÚ ¹ß»ý »óÇÇ¿¡¼­ Á¦ÀÏ Å« ¼¼Æ÷ÇüÀÌ¸ç ¿°»öü ¼ö´Â 2nÀ¸·Î¼­ Á¤Á¶ ¼¼Æ÷¿Í °°À¸³ª, DNA¸¦ º¹Á¦ÇÏ¿© 4nÀÇ DNA¾çÀ» °®´Â´Ù.
  • primary stage
    Ãʱâ
  • primary suture
    ÀÏÂ÷ ºÀÇÕ
  • primary syphilis
    Àϱ⠸ŵ¶, Ãʱ⠸ŵ¶, ÀÏÂ÷ ¸Åµ¶
    10-90ÀÏÀÇ Àẹ±â ÈÄ ±ÕÀÌ Ä§ÀÔÇÑ ºÎÀ§¿¡ Çϰ¨
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
homotropic effect An effect where two identical ligands (small molecules) allosterically interact with each other.
(09 Oct 1997)
Purkinje effect <ophthalmology> In the light-adapted eye, the region of maximal brightness is in the yellow; in the dark-adapted eye, the region of maximal brightness is in the green.
Synonym: Purkinje effect, Purkinje shift.
(05 Mar 2000)
hydrophobic effect <chemistry> The tendency for the nonpolar portions of a group of lipid molecules to clump together with one another and exclude water and other polar molecules. The polar portions of the lipid molecules end up facing out. The hydrophobic effect is primarily responsible for the construction of lipid bilayers.
(09 Oct 1997)
side effect <pharmacology> A consequence other than the one for which an agent or measure is used, as the adverse effects produced by a drug, especially on a tissue or organ system other than the one sought to be benefited by its administration.
For example: hair loss may be a side effect of chemotherapy, fatigue may be a side effect of radiation therapy.
(14 Oct 1997)
hyperchromic effect An increase in absorptivity (or extinction) at a particular wavelength of light by a solution or substance due to structural changes in a molecule.
(05 Mar 2000)
sigma effect The decrease in apparent viscosity that occurs when a suspension, such as blood, is made to flow through a tube of smaller diameter; observed in tubes less than about 0.3 mm in diameter.
Synonym: sigma effect.
(05 Mar 2000)
hypochromic effect A phenomenon in which an individual molecule, containing several chromophores, has a certain absorptivity (or optical density) at a given wavelength that is less than the sum of the optical densities of the individual chromophores (at that same wavelength).
(05 Mar 2000)
Somogyi effect In diabetes, a rebound phenomenon of reactive hyperglycaemia in response to a preceding period of relative hypoglycaemia that has increased secretion of hyperglycaemic agents (epinephrine, norepinephrine, glucagon, cortisol, and growth hormone); described in diabetic patients given too much insulin who developed unrecognised nocturnal hypoglycaemia that made them hyperglycaemic (suggesting insufficient insulin) when tested the next morning.
(05 Mar 2000)
stark effect <radiobiology> The effect an electric field has on the spectral lines emitted from excited atoms.
The effect may arise from externally-applied electric fields, from internal fields due to the presence of neighboring ions or atoms (pressure), or from the electric field associated with the Lorentz (v cross B) force (motional stark effect). Spectroscopic measurements of plasmas using the pressure-based and motional Stark effects are useful for diagnostic purposes.
(09 Oct 1997)
Staub-Traugott effect In normal persons, a drop in blood glucose which follows a second oral dose of glucose given 30 minutes or so after the first.
(05 Mar 2000)
Stiles-Crawford effect Light that enters through the centre of the pupil produces a greater visual effect than light that enters obliquely.
(05 Mar 2000)
no-observed-adverse-effect level The highest dosage administered that does not produce toxic effects. The noael will depend on how closely dosages are spaced (lowest-observed-adverse-effect level and no-observed-effect level) and the number of animals examined. The ultimate objective is usually to determine not the "safe" dosage in laboratory animals but the "safe" dosage for humans. Therefore, the extrapolation most often required of toxicologists is from high-dosage studies in laboratory animals to low doses in humans. (casarett and doull's toxicology: the basic science of poisons, 4th ed)
(12 Dec 1998)
nuclear Overhauser effect <enzyme> An enzyme seen in nuclear magnetic resonance in which there is a through-space nearest neighbor interaction.
(05 Mar 2000)
synergistic effect The doctrine or theory, attributed to Melanchthon, that in the regeneration of a human soul there is a cooperation, or joint agency, on the part both of God and of man.
See: Synergetic.
Source: Websters Dictionary
(01 Mar 1998)
doppler effect <radiobiology> Variation in the frequency of a wave (as measured by an observer) due to relative motion between the observer and the source of the wave. (The observed frequency increases if the source is moving towards the observer and vice versa.) The equation can be found in most optics texts and many introductory physics texts.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary stress
    =PRIMARY ACCENT
  • primary structure
    ÃÊ¿øÀû ±¸Á¶¹°(ÃÖ¼ÒÇÑÀÇ Á¶Çü ¼ö´ÜÀ¸·Î Á¦À۵Ǵ ÀüÀ§ Á¶°¢)
  • primary tenses
    (¶óƾ,±×¸®½º¾îÀÇ) Á¦ 1½ÃÁ¦(ÇöÀç,¹Ì·¡,°ú°Å ¶Ç´Â ¿Ï·áÀÇ ÃÑĪ)
  • primary wall
    (¼¼Æ÷¸·ÀÇ) 1Â÷¸·
  • runoff primary
    °á¼± ÅõÇ¥(µÎ ÃÖ°í µæÇ¥ÀÚÁß Áö¸í È帰¡ µÉ »ç¶÷À» Á¤ÇÏ´Â)
  • white primary
    ¹éÀÎ ¿¹¼±È¸(¹Ì±¹ ³²ºÎ ¿©·¯ ÁÖÀÇ ¹éÀθ¸ÀÌ ÅõÇ¥ÇÏ´ø ¹ÎÁÖ´çÀÇ ¿¹ºñ ¼±°Å)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á